Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Clear earnings/guidance catalyst: Q2 2026 EPS of $1.26 beat $0.99 consensus, and management raised 2026 operating EPS guidance by 8% at the midpoint. Shares recovered steadily to the 21-day high, supported by favorable insurance-sector rotation.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Strong Cash Flow ⢠High Leverage ⢠Modest Returns CNO offers strong cash generation and asset backing, but high leverage, modest returns, and a richer valuation warrant caution.
Price Behavior
Key Price Behavior Insights: ⢠Higher lows ⢠Fading momentum ⢠Breakout needed Support Level: $54.00â$54.40 Resistance Level: $55.70â$56.60 CNO remains modestly constructive above $54.00 support, but fading momentum requires a breakout above $56.60 to confirm further upside.
Sentiment & News
Key News Insights: ⢠Worksite Expansion ⢠New Investor Stakes ⢠Mixed Holdings CNO's growth strategy and rising investor interest are tempered by mixed institutional positioning, supporting a cautiously positive outlook.
AI Summary
CNO's investment case has shifted to a productivity-led earnings storyâsales and income outpacing agent growth could lift historically modest returnsâbut with valuation already richer, investors should require sustained margin/ROE improvement and monitor leverage, rate-driven book-value volatility, and Medicare execution before adding exposure.
Description
CNO Financial Group, through its subsidiaries, underwrites and administers a range of life, health and annuity products for middle-income and senior customers in the United States, including Medicare-related coverage, supplemental health and long-term care offerings. The company distributes its products via agents, independent producers, direct channels and worksite/group relationships, and markets under the Bankers Life, Washington National and Colonial Penn brands. Founded in 1979, CNO is headquartered in Carmel, Indiana.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Jul 31 | Aug 7 | CNO | CNO Financial Group, Inc. | Clear earnings/guidance catalyst: Q2 2026 EPS of $1.26 beat $0.99 consensus, and management raised 2026 operating EPS guidance by 8% at the midpoint. Shares recovered steadily to the 21-day high, supported by favorable insurance-sector rotation. | Closed | +0.1% |